FIELD: medicine; pharmaceutics.
SUBSTANCE: invention describes pharmaceutical compositions for use in treating or preventing a C5-related disease, and methods of treating or preventing a C5-related disease. Application also describes doses and administration schedules of the anti-C5 antibody or pharmaceutical compositions containing the anti-C5 antibody.
EFFECT: treating or preventing a c5-related disease.
11 cl, 11 dwg, 4 tbl, 11 ex
| Title |
Year |
Author |
Number |
| PHARMACEUTICAL COMPOSITION INTENDED FOR USE FOR TREATMENT OR PREVENTION OF C5-RELATED DISEASE AND METHOD FOR TREATMENT OR PREVENTION OF C5-RELATED DISEASE |
2019 |
- Shinomiya Kenji
- Gotanda Keisuke
- Nishimura Jun-Ichi
- Winter Erica
- Hsu Joy C.
|
RU2789389C2 |
| DOSAGE AND REGIMEN FOR TREATING OR PREVENTING C5-RELATED DISEASES BY USING ANTI-C5 CROVALIMAB ANTIBODY |
2020 |
- Sostelli, Aleksandr Antuan Bernar
- Buatua, Simon Bertran Mari
- Subre, Antuan
- Zhaminon, Feliks Greguar Zhazon
- Jordan, Gregor
- Busher, Kristof
- Sharuan, Zhan-Erik
|
RU2832188C2 |
| COMPOSITION FOR PREVENTION OR TREATMENT OF IL-8-RELATED DISEASES |
2017 |
- Kakiuti Ayako
- Kato Atsukhiko
- Khayasi Syudzi
- Yanagisava Idzumi
- Konno Re
- Netsu Satikho
- Sankai Tadasi
|
RU2766112C2 |
| CD40L ANTIBODIES AND METHODS OF TREATING CD40L RELATED DISEASES AND DISORDERS |
2016 |
- Lincecum John M.
- Jiang Bingbing
- Perrin Steven N.
- Gill Alan
- Gill Cynthia A.
- Vieira Fernando G.
|
RU2727646C2 |
| PHARMACEUTICAL COMPOSITION FOR USE IN PREVENTING AND/OR TREATING A DISEASE THAT DEVELOPS OR PROGRESSES AS A RESULT OF REDUCING OR LOSING ACTIVITY OF THE BLOOD COAGULATION FACTOR VIII AND/OR ACTIVATED COAGULATION FACTOR VIII |
2015 |
|
RU2721910C2 |
| METHOD OF TREATING DISEASES ASSOCIATED WITH CHOLESTEROL |
2021 |
- Zhang, Lianshan
- Zhu, Bo
- Xia, Jing
|
RU2832333C1 |
| C5 ANTIBODIES AND THEIR APPLICATION METHODS |
2015 |
- Ruike Esinao
- Sampej Dzendziro
|
RU2746356C2 |
| METHODS OF PREVENTING AND TREATING HEART DISEASES |
2018 |
- Rozenvejg, Entoni
- Ro, Dzhejson, D.
- Glass, Dejvid, Dzh.
|
RU2830232C2 |
| ANTI-C5 ANTIBODIES AND METHODS FOR THEIR USE |
2017 |
- Rujke Esinao
- Sampej Dzendziro
|
RU2789788C2 |
| DOSES AND ADMINISTRATION OF ANTIBODIES AGAINST C5 FOR TREATMENT OF ATYPICAL HEMOLYTIC UREMIC SYNDROME (aHUS) |
2020 |
- Pejton, Lori
- Miks, Kristian
- Pradkhan, Radzhendra
- Damokosh, Andryu
- Svenson, Yudzhin Skott
- Gao, Syan
|
RU2822664C2 |
